Logo image of BTAI

BIOXCEL THERAPEUTICS INC (BTAI) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:BTAI - US09075P2048 - Common Stock

1.84 USD
-0.07 (-3.66%)
Last: 1/16/2026, 8:00:02 PM
1.8599 USD
+0.02 (+1.08%)
After Hours: 1/16/2026, 8:00:02 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
BTAI revenue by date.BTAI revenue by date.
380K1.38M
263.16%
2.266M
64.20%
585.072K
-74.18%
2.139M
265.60%
33.507M
1,466.48%
164.83M
391.93%
287.23M
74.26%
443.9M
54.55%
565.08M
27.30%
696.35M
23.23%
838.44M
20.40%
EBITDA
YoY % growth
BTAI ebitda by date.BTAI ebitda by date.
-159.32M
-49.40%
-167.301M
-5.01%
-64.495M
61.45%
-55.719M
13.61%
-62.067M
-11.39%
-73.741M
-18.81%
-54.672M
25.86%
28.764M
152.61%
149.23M
418.81%
247.04M
65.54%
355.67M
43.97%
476.14M
33.87%
EBIT
YoY % growth
BTAI ebit by date.BTAI ebit by date.
-159.65M
-49.29%
-167.619M
-4.99%
-64.804M
61.34%
-52.973M
18.26%
-50.159M
5.31%
-65.851M
-31.29%
-55.692M
15.43%
27.744M
149.82%
148.21M
434.21%
246.02M
65.99%
354.65M
44.15%
475.12M
33.97%
Operating Margin
BTAI operating margin by date.BTAI operating margin by date.
-42,013.16%-12,146.30%-2,859.84%-9,054.08%-2,344.96%-196.53%-33.79%9.66%33.39%43.54%50.93%56.67%
EPS
YoY % growth
BTAI eps by date.BTAI eps by date.
-94.59
-44.90%
-98.40
-4.03%
-25.97
73.61%
-6.58
74.67%
-3.19
51.53%
-2.65
16.99%
-1.11
58.00%
0.54
148.62%
2.70
400.00%
4.18
54.72%
5.59
33.66%
6.93
23.91%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.83
76.64%
-0.74
50.87%
-0.69
72.00%
-0.77
64.79%
-0.72
13.46%
Revenue
Q2Q % growth
179.52K
-50.95%
374.003K
122.62%
408K
240.00%
408K
316.33%
612K
240.91%
EBITDA
Q2Q % growth
-14.882M
-46.59%
-12.572M
-25.43%
-15.708M
-0.04%
-16.483M
-19.37%
-21.318M
-43.25%
EBIT
Q2Q % growth
-12.547M
-19.94%
-11.983M
-18.65%
-14.074M
11.22%
-14.557M
-3.72%
-16.011M
-27.61%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-2.18
57.42%
-1.20-0.98-81.51%
Q2 2025
Q2Q % growth
-2.45
27.08%
-1.89-0.56-29.42%
Q1 2025
Q2Q % growth
-1.50
89.22%
-6.795.2977.91%
Q4 2024
Q2Q % growth
-3.57
70.64%
-6.552.9845.53%
Q3 2024
Q2Q % growth
-5.12
81.40%
-8.843.7242.08%
Q2 2024
Q2Q % growth
-3.36
88.52%
-11.598.2371.00%
Q1 2024
Q2Q % growth
-13.92
52.72%
-11.40-2.52-22.14%
Q4 2023
Q2Q % growth
-12.16
61.03%
-14.852.6918.12%
Q3 2023
Q2Q % growth
-27.52
-15.28%
-21.28-6.24-29.32%
Q2 2023
Q2Q % growth
-29.28
-35.56%
-28.57-0.71-2.47%
Q1 2023
Q2Q % growth
-29.44
-64.29%
-26.41-3.03-11.48%
Q4 2022
Q2Q % growth
-31.20
-109.68%
-23.60-7.60-32.18%
Q3 2022
Q2Q % growth
-23.87
-55.42%
-22.03-1.84-8.35%
Q2 2022
Q2Q % growth
-21.60
-21.62%
-19.90-1.70-8.57%
Q1 2022
Q2Q % growth
-17.92
-3.70%
-18.710.794.24%
Q4 2021
Q2Q % growth
-14.88
-6.90%
-18.023.1417.41%
Q3 2021
Q2Q % growth
-15.36
10.28%
-17.151.7910.45%
Q2 2021
Q2Q % growth
-17.76
-4.72%
-17.71-0.05-0.30%
Q1 2021
Q2Q % growth
-17.28
-36.71%
-15.32-1.96-12.79%
Q4 2020
Q2Q % growth
-13.92 -15.621.7010.87%
Q3 2020
Q2Q % growth
-17.12 -13.04-4.08-31.31%
Q2 2020
Q2Q % growth
-16.96 -12.22-4.74-38.77%
Q1 2020
Q2Q % growth
-12.64 -9.71-2.93-30.17%
BTAI Yearly EPS VS EstimatesBTAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -20 -40 -60 -80
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
98K
-54.21%
216.75K-118.75K-54.79%
Q2 2025
Q2Q % growth
120K
-89.13%
255K-135K-52.94%
Q1 2025
Q2Q % growth
168K
-71.13%
435.203K-267.203K-61.40%
Q4 2024
Q2Q % growth
366K
-2.66%
720.803K-354.803K-49.22%
Q3 2024
Q2Q % growth
214K
-37.24%
1.332M-1.118M-83.93%
Q2 2024
Q2Q % growth
1.104M
141.58%
774.384K329.616K42.56%
Q1 2024
Q2Q % growth
582K
182.52%
473.28K108.72K22.97%
Q4 2023
Q2Q % growth
376K
56.67%
725.353K-349.353K-48.16%
Q3 2023
Q2Q % growth
341K
143.57%
673.2K-332.2K-49.35%
Q2 2023
Q2Q % growth
457K 462.968K-5.968K-1.29%
Q1 2023
Q2Q % growth
206K 509.072K-303.072K-59.53%
Q4 2022
Q2Q % growth
240K 1.273M-1.033M-81.15%
Q3 2022
Q2Q % growth
140K 1.116M-976K-87.46%
Q1 2022
Q2Q % growth
127.5K-127.5K-100.00%
BTAI Yearly Revenue VS EstimatesBTAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-6.86% -10.47% -8.15% -21.55%
Revenue0.57% -39.73% -6.52% -26.11%